Viveve Medical, Inc.

VIVE · OTC
Analyze with AI
9/30/2022
6/30/2022
3/31/2022
12/31/2021
Operating Activities
Net Income-$4,976-$5,799-$5,886-$6,328
Dep. & Amort.$174$188$204$240
Deferred Tax$0$0$0-$1,264
Stock-Based Comp.$868$909$960$1,014
Change in WC$395-$505-$648$1,525
Other Non-Cash$189$639$283$1,586
Operating Cash Flow-$3,350-$4,568-$5,087-$3,227
Investing Activities
PP&E Inv.-$193-$59-$49-$294
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$193-$59-$49-$294
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$1,263-$25,788
Stock Repurch.$0$0$19$704
Dividends Paid$0$0$0-$4,685
Other Fin. Act.$19$13$19$4,703
Financing Cash Flow$19$13$19$18
Forex Effect$0$0$0$0
Net Chg. in Cash-$3,524-$4,614-$5,117-$3,503
Supplemental Information
Beg. Cash$9,431$14,045$19,162$22,665
End Cash$5,907$9,431$14,045$19,162
Free Cash Flow-$3,543-$4,627-$5,136-$3,521
Viveve Medical, Inc. (VIVE) Financial Statements & Key Stats | AlphaPilot